🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
313,52 USD
Máx. histórico
322,75
4 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-2,86%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,12%
Cierre anterior
307,02
Rango de hoy
309,46 – 317,76
Volumen hoy
195.564
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 33,04 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 9 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 26/07/2024 | 106,99 | 108,42 | 105,75 | 107,14 | +1,07% | 2,50% | 88.700 |
| 25/07/2024 | 104,13 | 108,91 | 101,56 | 106,01 | +2,97% | 7,06% | 200.600 |
| 24/07/2024 | 102,00 | 105,35 | 101,50 | 102,95 | +0,57% | 3,77% | 77.700 |
| 23/07/2024 | 100,92 | 104,00 | 100,92 | 102,37 | +0,91% | 3,05% | 75.800 |
| 22/07/2024 | 100,33 | 102,50 | 98,04 | 101,45 | +1,69% | 4,45% | 104.800 |
| 19/07/2024 | 99,19 | 101,70 | 98,33 | 99,76 | +0,81% | 3,40% | 82.200 |
| 18/07/2024 | 100,50 | 101,51 | 98,75 | 98,96 | -2,09% | 2,75% | 88.300 |
| 17/07/2024 | 97,66 | 101,92 | 97,66 | 101,07 | +2,14% | 4,36% | 174.300 |
| 16/07/2024 | 97,94 | 99,98 | 95,61 | 98,95 | +2,36% | 4,46% | 124.700 |
| 15/07/2024 | 100,00 | 100,00 | 95,89 | 96,67 | -2,76% | 4,11% | 142.900 |
| 12/07/2024 | 99,21 | 100,69 | 96,90 | 99,41 | +1,44% | 3,82% | 157.000 |
| 11/07/2024 | 97,30 | 99,10 | 95,54 | 98,00 | +1,77% | 3,66% | 160.800 |
| 10/07/2024 | 92,00 | 97,80 | 91,61 | 96,30 | +5,00% | 6,73% | 322.600 |
| 09/07/2024 | 87,78 | 91,91 | 87,28 | 91,71 | +5,56% | 5,27% | 217.200 |
| 08/07/2024 | 85,89 | 92,90 | 85,18 | 86,88 | +2,97% | 8,99% | 215.800 |
| 05/07/2024 | 82,86 | 84,53 | 81,74 | 84,37 | +2,02% | 3,37% | 56.900 |
| 03/07/2024 | 84,90 | 84,90 | 82,22 | 82,70 | -2,46% | 3,16% | 63.100 |
| 02/07/2024 | 84,85 | 85,61 | 84,04 | 84,79 | -0,07% | 1,85% | 115.700 |
| 01/07/2024 | 83,76 | 85,72 | 82,98 | 84,85 | +0,70% | 3,27% | 145.700 |
| 28/06/2024 | 82,72 | 84,33 | 81,86 | 84,26 | +2,34% | 2,99% | 328.400 |
| 27/06/2024 | 78,45 | 82,88 | 78,20 | 82,33 | +5,80% | 5,97% | 115.300 |
| 26/06/2024 | 78,45 | 79,03 | 77,53 | 77,82 | -1,37% | 1,91% | 83.700 |
| 25/06/2024 | 80,00 | 80,30 | 78,44 | 78,90 | -1,33% | 2,33% | 83.600 |
| 24/06/2024 | 79,81 | 81,20 | 79,81 | 79,96 | +0,72% | 1,74% | 72.500 |
| 21/06/2024 | 79,92 | 81,12 | 79,07 | 79,39 | -0,53% | 2,57% | 181.700 |
| 20/06/2024 | 79,90 | 81,01 | 79,33 | 79,81 | -0,91% | 2,10% | 69.600 |
| 18/06/2024 | 80,27 | 81,29 | 79,50 | 80,54 | -0,12% | 2,23% | 92.300 |
| 17/06/2024 | 80,00 | 80,75 | 77,58 | 80,64 | +0,72% | 3,96% | 94.900 |
| 14/06/2024 | 81,04 | 81,23 | 78,81 | 80,06 | -1,57% | 2,99% | 85.100 |
| 13/06/2024 | 80,17 | 81,52 | 78,91 | 81,34 | +1,48% | 3,26% | 71.800 |